BRIEF-Nanoviricides Says NV-387 Shows Activity Against Measles Virus In Humanized Animal Model

Reuters
2025/10/21
BRIEF-Nanoviricides Says NV-387 Shows Activity Against Measles Virus In Humanized Animal Model

Oct 20 (Reuters) - NanoViricides Inc NNVC.A:

  • NANOVIRICIDES: CLINICAL LEAD DRUG NV-387 HAS SHOWN STRONG ACTIVITY AGAINST MEASLES VIRUS IN A HUMANIZED ANIMAL MODEL

  • NANOVIRICIDES: NV-387 CAN NOW BE MADE AVAILABLE FOR EMERGENCY USE APPLICATION IN MEASLES PATIENTS TO RESPOND TO SPREADING MEASLES OUTBREAKS

  • NANOVIRICIDES: NV-387 HAS ALREADY COMPLETED PHASE I CLINICAL TRIAL IN HEALTHY SUBJECTS WITH NO REPORTED ADVERSE EVENTS

Further company coverage: NNVC.A

((((Reuters.Briefs@thomsonreuters.com));))

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10